Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bronchodilators

  • Detecting reversible airway disease in those born preterm – which is the best test?
    T Bradshaw, S Simpson, D Evans, N Hemy, R Urs, E Smith
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1578; DOI: 10.1183/13993003.congress-2022.1578
  • Effects of acute bronchodilators on ventilatory constraint and dyspnoea during exercise in patients with pulmonary arterial hypertension (PAH)
    E Schroeder, D C Berton, L R Diello, S D D Melati, M B Gazzana, E V M Ferreira, E V Ferreira
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1898; DOI: 10.1183/13993003.congress-2022.1898
  • Association of Early Life Factors with Prematurity-Associated Lung Disease : Prospective Cohort Study
    S Kotecha, K Hart, M Cousins, W J Watkins, A J Henderson, S Kotecha
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1183; DOI: 10.1183/13993003.congress-2022.1183
  • Effects of salbutamol and ipratropium on human stem-cells derived cardiomyocytes’ function
    M Scurek, S Klimovic, M Pesl, J Pribyl, D Kabanov, D Beckerova, M Bebarova, V Rotrekl, K Brat
    European Respiratory Journal Sep 2022, 60 (suppl 66) 560; DOI: 10.1183/13993003.congress-2022.560
  • Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma.
    L Nannini, N Neumayer, N Brandan, O Fernandez
    European Respiratory Journal Sep 2022, 60 (suppl 66) 483; DOI: 10.1183/13993003.congress-2022.483
  • Bronchodilator response for oscillometry in severe eosinophilic asthma
    R Chan, C R W Kuo, B Lipworth
    European Respiratory Journal Sep 2022, 60 (suppl 66) 1; DOI: 10.1183/13993003.congress-2022.1
  • Reversibility at pulmonary function tests: can it have implications in patients with COPD?
    Kostiantyn Dmytriiev, Yuriy Mostovoy, Nataliia Slepchenko, Dmytro Dmytriiev
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3836; DOI: 10.1183/13993003.congress-2021.PA3836
  • Drug Delivery Performance and Fugitive Emission Comparison of Two Commercially Available Nebulizer Systems
    Mark Nagel, Nathaniel Hoffman, Jason Suggett
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3402; DOI: 10.1183/13993003.congress-2021.PA3402
  • Lung deposition and distribution of inhaled extra fine beclomethasone dipropionate / formoterol fumarate /glycopyrronium bromide (BDP/FF/GB) in subjects with and without airflow obstruction
    Simonetta Baldi, Omar Usmani, Simon Warren, Ilaria Panni, Luca Girardello, François Rony, Glyn Taylor, Wilfried De Backer, George Georges
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3396; DOI: 10.1183/13993003.congress-2021.PA3396
  • Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients
    Patricia Sobradillo Ecenarro, Nuria Marina, Silvia Pérez-Fernández, Eva Tabernero, Milagros Iriberri, Bartolomé Celli
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3437; DOI: 10.1183/13993003.congress-2021.PA3437

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 48
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (499)
  • Lung biology and experimental studies (318)
  • Lung cancer (282)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (973)
  • Sleep medicine (267)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society